SkyView Investment Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
SkyView Investment Advisors's NVS Position: Q2 2023 in Review
SkyView Investment Advisors sold out of Novartis (NVS) in Q2 2023, closing a stake of 9,241 shares — an estimated $850K sold.
SkyView Investment Advisors first reported a position in NVS in Q2 2022 and held it in 4 quarters. The position peaked at $850K in Q1 2023. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.
- SkyView Investment Advisors reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
- SkyView Investment Advisors sold 9,241 Novartis shares in Q2 2023, an estimated $850K.
- SkyView Investment Advisors first reported a position in Novartis in Q2 2022 and held it in 4 quarters.
- SkyView Investment Advisors's Novartis position peaked at $850K in Q1 2023.
- 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.
Based on SkyView Investment Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.